Agents that generate reactive oxygen species (ROS) are recog-nized to enhance MDA-7/IL-24 lethality. The present studies fo-cused on clarifying how such agents enhanced MDA-7/IL-24 tox-icity in renal cell carcinoma cells (RCCs). Infection of RCCs with a tropism-modified serotype 5/3 adenovirus expressing MDA-7/ IL-24 (Ad.5/3-mda-7) caused plasma membrane clustering of CD95 and CD95 association with pro-caspase 8, effects that were enhanced by combined exposure to 17-N-allylamino-17-demethoxygeldanamycin (17AAG), As2O3, or fenretinide and that correlated with enhanced cell killing. Knockdown of CD95 or expression of cellular FADD (Fas-associated protein with death domain)-like interleukin-1–converting enzyme inhibitory protein, short form (c...
Myeloid derived suppressor cells (MDSC, CD33+CD11b+ HLA-DR low/-) play a major role in tumor-mediate...
Adenoviral gene therapy holds great potential for cancer treatment, but is limited by a lack of effi...
The application of synthetic ceramides to U937 monocytes for short (2 hours) or long (16 hours) trea...
The median survival of metastatic renal cell carcinoma (RCC) is 12 months, and the majority of treat...
The impact of Ad.mda-7 on the survival of renal cell carcinoma lines (RCC), primary renal epithelial...
We developed several adenoviral vectors designed to target MDA-7 expression to different subcellular...
Objective. Melanoma differentiation associated gene-7 [mda-7/interleukin (IL)-24] has been identifie...
Objective. We have previously shown that adenoviral-mediated melanoma differentiation-associated gen...
Despite evidence that antitumor immunity can be protective against renal cell carcinoma (RCC), few p...
Many cancers can become resistant to repeated administration of even the most effective therapeutic ...
Renal cancer is a common and deadly disease that lacks curative treatments when metastatic. Here, we...
For long it has been recognized that tumor necrosis factor alpha (TNFa) has anticancer characteristi...
Despite evidence that antitumor immunity can be protective against renal cell carcinoma (RCC), few p...
Although treatment strategies for advanced and metastatic clear cell renal cell carcinoma (ccRCC) ha...
<div><p>Durable tumor cell eradication by chemotherapy is challenged by the development of multidrug...
Myeloid derived suppressor cells (MDSC, CD33+CD11b+ HLA-DR low/-) play a major role in tumor-mediate...
Adenoviral gene therapy holds great potential for cancer treatment, but is limited by a lack of effi...
The application of synthetic ceramides to U937 monocytes for short (2 hours) or long (16 hours) trea...
The median survival of metastatic renal cell carcinoma (RCC) is 12 months, and the majority of treat...
The impact of Ad.mda-7 on the survival of renal cell carcinoma lines (RCC), primary renal epithelial...
We developed several adenoviral vectors designed to target MDA-7 expression to different subcellular...
Objective. Melanoma differentiation associated gene-7 [mda-7/interleukin (IL)-24] has been identifie...
Objective. We have previously shown that adenoviral-mediated melanoma differentiation-associated gen...
Despite evidence that antitumor immunity can be protective against renal cell carcinoma (RCC), few p...
Many cancers can become resistant to repeated administration of even the most effective therapeutic ...
Renal cancer is a common and deadly disease that lacks curative treatments when metastatic. Here, we...
For long it has been recognized that tumor necrosis factor alpha (TNFa) has anticancer characteristi...
Despite evidence that antitumor immunity can be protective against renal cell carcinoma (RCC), few p...
Although treatment strategies for advanced and metastatic clear cell renal cell carcinoma (ccRCC) ha...
<div><p>Durable tumor cell eradication by chemotherapy is challenged by the development of multidrug...
Myeloid derived suppressor cells (MDSC, CD33+CD11b+ HLA-DR low/-) play a major role in tumor-mediate...
Adenoviral gene therapy holds great potential for cancer treatment, but is limited by a lack of effi...
The application of synthetic ceramides to U937 monocytes for short (2 hours) or long (16 hours) trea...